+49 30 648 35 164 service@chameleon-pharma.com

All about football? Will the World Cup take over the “B” of BRIC countries?

Organising a huge event like the FIFA World Cup is a great evidence of Brazil’s economic growth, and the country is now very strong and competitive on the global arena. There’s no doubt that Brazil is very appealing to global business players, who want to make new massive investments that will, in turn, accelerate further development in different segments of the Brazilian economy, such as Pharma and Consumer Health Market.

Don’t miss a big opportunity to make a profit serving Brazil’s Pharma market, the second-largest in the emerging world, and its growing middle class!

Many multinational Pharma companies have intensified their participation in the Brazilian Pharma market, and for good reason: Brazil enjoys the biggest share (40%) of the Latin American Pharma market. Currently one of the fastest-growing healthcare markets, it has always stayed robust and resilient even in periods of low economic activity. With its retail pharmaceutical market valued at US $26 billion in 2012, Brazil has currently the world’s eighth-largest drug market, and it is second among emerging countries after China.

The favourable environment and advantageous operating conditions in the Brazilian Pharma market continue to attract foreign Pharma and OTC companies. Recently more and more of them have been drawn to Brazil because of the growth drivers such as:

Key drivers of growth in Brazil

CPC Press Releases on Brazil:

Brazil: An Overview

Featured image at the top: Photo by Gabriel Rissi on Unsplash


Related Posts

Our services


International Company Partner Identification

Licensing and

Product Potential & Country Analysis

International Business & Market Entry


Pharma Regulatory & Registration

Pharma Executive

International Strategy & Analysis

Market Reports and Analysis